Sign in

Elizabeth Kuhn

@elizabethkuhn.bsky.social
54 followers 133 following 20 posts

Researcher (she/her) | With @neuropresage.bsky.social, Caen France 🇫🇷 | Formely at @dzne.science Bonn Germany 🇩🇪| SCD, Anosognosia, Alzheimer, Neurodegeneration, Aging | Communication Chair of the SCD PIA @istaart.bsky.social

PostsRepliesMedia
Elizabeth Kuhn @elizabethkuhn.bsky.social · 02/05/2026
I’m running for Vice Chair and Program Chair within SCD PIA. I would truly appreciate your support and vote to continue contributing to the executive committee in a new role! 🙏 Deadline May 27: act.alz.org/site/R?i=hEk... @istaart.bsky.social
act.alz.org
Single Sign On
101
Elizabeth Kuhn @elizabethkuhn.bsky.social · 15/04/2026
Excited to share that our paper « SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies » has been selected as one of the top 3 for ISTAART Publication of the Year Award 🏆 If you’re a PIA member, I’d be truly grateful for your vote!
alz-journals.onlinelibrary.wiley.com
SCD‐plus features and AD biomarkers in cognitively unimpaired samples: A meta‐analytic approach for nine cohort studies
INTRODUCTION Specific features of subjective cognitive decline (SCD-plus) have been proposed to indicate an increased risk of preclinical Alzheimer's disease (AD). However, few studies have examined...
201
Elizabeth Kuhn @elizabethkuhn.bsky.social · 19/03/2026
Brain Awareness Week 🧠 Honored to have received the Young Researcher in Neuroscience Award 🏆 and presented my work for the Fondation Planiol. Thanks to the organizers, the other awardee, and everyone who makes research possible 🙏 pubmed.ncbi.nlm.nih.gov/39985404/
pubmed.ncbi.nlm.nih.gov
SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies - PubMed
About two-tenths of our sample had abnormal amyloid beta (Aβ) levels with evidence of subjective cognitive decline (SCD). Preclinical AD subsamples (community-based) had a higher percentage of participants meeting SCD-plus features. Self-reported memory decline and concern/worry were the sole featur …
010
Elizabeth Kuhn @elizabethkuhn.bsky.social · 24/02/2026
Interested in getting more involved in the SCD research community? Self-nominations are open for the @istaart.bsky.social #SCDPIA executive committee! A great chance to collaborate, contribute ideas, and help shape upcoming initiatives. alz.surveymonkey.com/r/7YJN6YB
alz.surveymonkey.com
2026 ISTAART PIA Executive Committee Self-Nominations
Take this survey powered by surveymonkey.com. Create your own surveys for free.
000
Elizabeth Kuhn @elizabethkuhn.bsky.social · 16/02/2026
On January 23rd, Anna Aaronson presented the 2025 SCD Year in review, highlighting interesting papers published this year in the field. Some of them are directly related to the #SCDPIA Here is a short recap thread on 12 of the 897 published👇 #SCD #Alzheimers @istaart.bsky.social
300
Elizabeth Kuhn @elizabethkuhn.bsky.social · 10/11/2025
🧠✨ Help us prepare the @istaart.bsky.social #SCDPIA Year in Review 2025–2026! What were the key topics, advances, and publications in SCD research this year? Share your insights by Dec 5 using this form 👇 alz.surveymonkey.com/r/FSG8RXX
alz.surveymonkey.com
ISTAART PIAs: Year in Review Jan 2026
Submit your favorite papers from 2025!
011
Elizabeth Kuhn @elizabethkuhn.bsky.social · 05/11/2025
Have you read an outstanding study on subjective cognitive decline (SCD) published in 2025? Nominate it for the 2025 @istaart.bsky.social #SCDPIA Publication of the Year Award! alz.surveymonkey.com/r/Publicatio... ✅ Self-nominations are welcome 🗓️ Open until February 2026 #SCD #Alzheimer
alz.surveymonkey.com
Publication of the Year Award - Nomination
Thank you for submitting your Nomination!
020